These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 37338165

  • 1. Duloxetine prevents bortezomib and paclitaxel large-fiber chemotherapy-induced peripheral neuropathy (LF-CIPN) in sprague dawley rats.
    Mansooralavi N, Khomula EV, Levine JD.
    Mol Pain; 2023; 19():17448069231185694. PubMed ID: 37338165
    [Abstract] [Full Text] [Related]

  • 2. Neuroendocrine Stress Axis-Dependence of Duloxetine Analgesia (Anti-Hyperalgesia) in Chemotherapy-Induced Peripheral Neuropathy.
    Staurengo-Ferrari L, Bonet IJM, Araldi D, Green PG, Levine JD.
    J Neurosci; 2022 Jan 19; 42(3):405-415. PubMed ID: 34880120
    [Abstract] [Full Text] [Related]

  • 3. Effect of duloxetine in Japanese patients with chemotherapy-induced peripheral neuropathy: a pilot randomized trial.
    Hirayama Y, Ishitani K, Sato Y, Iyama S, Takada K, Murase K, Kuroda H, Nagamachi Y, Konuma Y, Fujimi A, Sagawa T, Ono K, Horiguchi H, Terui T, Koike K, Kusakabe T, Sato T, Takimoto R, Kobune M, Kato J.
    Int J Clin Oncol; 2015 Oct 19; 20(5):866-71. PubMed ID: 25762165
    [Abstract] [Full Text] [Related]

  • 4. Role of pattern recognition receptors in chemotherapy-induced neuropathic pain.
    Araldi D, Khomula EV, Bonet IJM, Bogen O, Green PG, Levine JD.
    Brain; 2024 Mar 01; 147(3):1025-1042. PubMed ID: 37787114
    [Abstract] [Full Text] [Related]

  • 5. Drug treatment for chemotherapy-induced peripheral neuropathy in patients with pancreatic cancer.
    Sugimoto M, Takagi T, Suzuki R, Konno N, Asama H, Sato Y, Irie H, Okubo Y, Nakamura J, Takasumi M, Hashimoto M, Kato T, Kobashi R, Hikichi T, Ohira H.
    Fukushima J Med Sci; 2022 Apr 08; 68(1):1-10. PubMed ID: 35197393
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Predictors of duloxetine response in patients with oxaliplatin-induced painful chemotherapy-induced peripheral neuropathy (CIPN): a secondary analysis of randomised controlled trial - CALGB/alliance 170601.
    Smith EM, Pang H, Ye C, Cirrincione C, Fleishman S, Paskett ED, Ahles T, Bressler LR, Le-Lindqwister N, Fadul CE, Loprinzi C, Shapiro CL, Alliance for Clinical Trials in Oncology.
    Eur J Cancer Care (Engl); 2017 Mar 08; 26(2):. PubMed ID: 26603828
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Duloxetine for prevention and treatment of chemotherapy-induced peripheral neuropathy (CIPN): systematic review and meta-analysis.
    Chow R, Novosel M, So OW, Bellampalli S, Xiang J, Boldt G, Winquist E, Lock M, Lustberg M, Prsic E.
    BMJ Support Palliat Care; 2023 Mar 08; 13(1):27-34. PubMed ID: 36194493
    [Abstract] [Full Text] [Related]

  • 11. Effects of the publication of Clinical Guidelines for the Management of Chemotherapy-Induced Peripheral Neuropathy on the Administration Preferences of Oncology Specialists: Japanese Association of Supportive Care in Cancer.
    Hirayama Y, Yoshida Y, Mori M, Tamura K.
    Jpn J Clin Oncol; 2020 Aug 04; 50(8):897-902. PubMed ID: 32424420
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Assessment of the Anti-Allodynic and Anti-Hyperalgesic Efficacy of a Glycine Transporter 2 Inhibitor Relative to Pregabalin, Duloxetine and Indomethacin in a Rat Model of Cisplatin-Induced Peripheral Neuropathy.
    Kuo A, Corradini L, Nicholson JR, Smith MT.
    Biomolecules; 2021 Jun 24; 11(7):. PubMed ID: 34202809
    [Abstract] [Full Text] [Related]

  • 15. Prazosin as an Adjuvant to Increase Effectiveness of Duloxetine in a Rat Model of Oxaliplatin-Induced Peripheral Neuropathy.
    Wagner MA, Smith EML, Ayyash N, Holden JE.
    Semin Oncol Nurs; 2024 Oct 24; 40(5):151686. PubMed ID: 38897856
    [Abstract] [Full Text] [Related]

  • 16. Analgesic Effects of Sokeikakketsuto on Chemotherapy-Induced Mechanical Allodynia and Cold Hyperalgesia in Rats.
    Nakamura H, Kawashiri T, Kobayashi D, Uchida M, Egashira N, Shimazoe T.
    Biol Pharm Bull; 2021 Oct 24; 44(2):271-274. PubMed ID: 33518680
    [Abstract] [Full Text] [Related]

  • 17. Recent Developments of Novel Pharmacologic Therapeutics for Prevention of Chemotherapy-Induced Peripheral Neuropathy.
    Hu S, Huang KM, Adams EJ, Loprinzi CL, Lustberg MB.
    Clin Cancer Res; 2019 Nov 01; 25(21):6295-6301. PubMed ID: 31123053
    [Abstract] [Full Text] [Related]

  • 18. Caspase-Dependent HMGB1 Release from Macrophages Participates in Peripheral Neuropathy Caused by Bortezomib, a Proteasome-Inhibiting Chemotherapeutic Agent, in Mice.
    Tsubota M, Miyazaki T, Ikeda Y, Hayashi Y, Aokiba Y, Tomita S, Sekiguchi F, Wang D, Nishibori M, Kawabata A.
    Cells; 2021 Sep 27; 10(10):. PubMed ID: 34685531
    [Abstract] [Full Text] [Related]

  • 19. Prevention, diagnosis and management of chemotherapy-induced peripheral neuropathy: a cross-sectional study of French oncologists' professional practices.
    Selvy M, Pereira B, Kerckhove N, Busserolles J, Farsi F, Guastella V, Merle P, Pezet D, Balayssac D.
    Support Care Cancer; 2021 Jul 27; 29(7):4033-4043. PubMed ID: 33403401
    [Abstract] [Full Text] [Related]

  • 20. Chemotherapy-induced peripheral neuropathy (CIPN) and its treatment: an NIH Collaboratory study of claims data.
    Gewandter JS, Kleckner AS, Marshall JH, Brown JS, Curtis LH, Bautista J, Dworkin RH, Kleckner IR, Kolb N, Mohile SG, Mustian KM.
    Support Care Cancer; 2020 Jun 27; 28(6):2553-2562. PubMed ID: 31494735
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.